Noteworthy IntraBiotics plans to run lean

IntraBiotics Pharmaceuticals Inc. was to announce today that it has raised $4 million in its first round financing, led by the Sprout Group. Other investors in the latest entrant in the antimicrobials field were Brinson Partners and St. Paul Ventures.

The Menlo Park, Calif., company is targeting drug-resistant bacteria and difficult-to-treat fungal infections using "intrabiotics," natural antimicrobial peptides that are produced as part of the internal host defense systems of humans